BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

811 related articles for article (PubMed ID: 28412093)

  • 21. Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up.
    Liauw SL; Sylvester JE; Morris CG; Blasko JC; Grimm PD
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):669-73. PubMed ID: 16887293
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers.
    Shiels MS; Gibson T; Sampson J; Albanes D; Andreotti G; Beane Freeman L; Berrington de Gonzalez A; Caporaso N; Curtis RE; Elena J; Freedman ND; Robien K; Black A; Morton LM
    J Clin Oncol; 2014 Dec; 32(35):3989-95. PubMed ID: 25385740
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased risk of additional cancers among patients with gastrointestinal stromal tumors: A population-based study.
    Murphy JD; Ma GL; Baumgartner JM; Madlensky L; Burgoyne AM; Tang CM; Martinez ME; Sicklick JK
    Cancer; 2015 Sep; 121(17):2960-7. PubMed ID: 25930983
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second primary malignancies in renal cortical neoplasms: an updated evaluation from a single institution.
    Murray KS; Zabor EC; Spaliviero M; Russo P; Bazzi WM; Musser JE; Ari Hakimi A; Bernstein ML; Dalbagni G; Coleman JA; Furberg H
    World J Urol; 2016 Dec; 34(12):1667-1672. PubMed ID: 27106493
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk.
    Chaturvedi AK; Engels EA; Gilbert ES; Chen BE; Storm H; Lynch CF; Hall P; Langmark F; Pukkala E; Kaijser M; Andersson M; Fosså SD; Joensuu H; Boice JD; Kleinerman RA; Travis LB
    J Natl Cancer Inst; 2007 Nov; 99(21):1634-43. PubMed ID: 17971527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of Second Lung Cancer in Patients with Previously Treated Lung Cancer: Analysis of Surveillance, Epidemiology, and End Results (SEER) Data.
    Thakur MK; Ruterbusch JJ; Schwartz AG; Gadgeel SM; Beebe-Dimmer JL; Wozniak AJ
    J Thorac Oncol; 2018 Jan; 13(1):46-53. PubMed ID: 28989038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
    Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
    Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of a new primary cancer among patients with lung cancer of different histological types.
    Teppo L; Salminen E; Pukkala E
    Eur J Cancer; 2001 Mar; 37(5):613-9. PubMed ID: 11290437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Risk of multiple primary cancers in prostate cancer patients in the Detroit metropolitan area: a retrospective cohort study.
    Pawlish KS; Schottenfeld D; Severson R; Montie JE
    Prostate; 1997 Oct; 33(2):75-86. PubMed ID: 9316648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of second malignancies in survivors of retinoblastoma: more than 40 years of follow-up.
    Marees T; Moll AC; Imhof SM; de Boer MR; Ringens PJ; van Leeuwen FE
    J Natl Cancer Inst; 2008 Dec; 100(24):1771-9. PubMed ID: 19066271
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence and prognostic impact of other cancers in a population of long-term survivors of chronic lymphocytic leukemia.
    Falchi L; Vitale C; Keating MJ; Lerner S; Wang X; Elhor Gbito KY; Strom S; Wierda WG; Ferrajoli A
    Ann Oncol; 2016 Jun; 27(6):1100-1106. PubMed ID: 26912560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of second malignant neoplasms among long-term survivors of testicular cancer.
    Travis LB; Curtis RE; Storm H; Hall P; Holowaty E; Van Leeuwen FE; Kohler BA; Pukkala E; Lynch CF; Andersson M; Bergfeldt K; Clarke EA; Wiklund T; Stoter G; Gospodarowicz M; Sturgeon J; Fraumeni JF; Boice JD
    J Natl Cancer Inst; 1997 Oct; 89(19):1429-39. PubMed ID: 9326912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
    Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
    J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Second primary tumors after prostate carcinoma.
    Levi F; Randimbison L; Te VC; Erler G; La Vecchia C
    Cancer; 1999 Oct; 86(8):1567-70. PubMed ID: 10526286
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nonendocrine cancers associated with benign and malignant parathyroid tumors.
    Fallah M; Kharazmi E; Sundquist J; Hemminki K
    J Clin Endocrinol Metab; 2011 Jul; 96(7):E1108-14. PubMed ID: 21525164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second primary cancers in the Vaud and Neuchâtel Cancer Registries.
    Levi F; Randimbison L; Rafael BM; Manuela MC; La Vecchia C
    Eur J Cancer Prev; 2015 Mar; 24(2):150-4. PubMed ID: 25397586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of Second Primary Cancer among Prostate Cancer Patients in Korea: A Population-Based Cohort Study.
    Joung JY; Lim J; Oh CM; Jung KW; Cho H; Kim SH; Seo HK; Park WS; Chung J; Lee KH; Won YJ
    PLoS One; 2015; 10(10):e0140693. PubMed ID: 26469085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Associations between ocular melanoma and other primary cancers: an international population-based study.
    Scélo G; Boffetta P; Autier P; Hemminki K; Pukkala E; Olsen JH; Weiderpass E; Tracey E; Brewster DH; McBride ML; Kliewer EV; Tonita JM; Pompe-Kirn V; Chia KS; Jonasson JG; Martos C; Giblin M; Brennan P
    Int J Cancer; 2007 Jan; 120(1):152-9. PubMed ID: 17036322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk of bladder cancer in patients diagnosed with other primary neoplasms: analysis of the SEER database.
    Anderson JK; Alanee S; Lindgren B; Slaton J
    Urol Oncol; 2013 Aug; 31(6):862-5. PubMed ID: 21784673
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk of second malignancies among survivors of pediatric thyroid cancer.
    Adly MH; Sobhy M; Rezk MA; Ishak M; Afifi MA; Shafie AE; Ali MA; Zekri W; Alfaar AS; Rashed WM
    Int J Clin Oncol; 2018 Aug; 23(4):625-633. PubMed ID: 29492793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.